To determine the relevance of our findings to human PDAC, we queried data on metastatic recurrence in PDAC patients after primary tumor removal, where SMAD4 status was evaluated by immunohistochemistry (IHC) staining of resected primary or metastatic tumors25,26. This evidence concerns the gene SMAD4 and neoplasm.